Novatti - The $1 party, page-4501

Biotech is one of the most risky investments you can get. It has a very high failure rate, As you would know with msb, you are at the whim of regulatory bodies, dependent on your market. You have many years of expensive trials with many cap raises which ultimately causes pretty heavy dilution, competition and deterrents from major pharmaceutical companies who already may have a treatment for your indication

like Warren says "know your product" about the treatment, drug, it's Moa, target market etc before you invest.

can also be extremely lucrative if you pick the right treatment. Good luck